Novartis Ag (NVS) Times Interest Earned (2009 - 2025)
Novartis Ag (NVS) posted Times Interest Earned of -$61.19 for Q2 2025, up 42.85% sequentially from -$107.06 in Q4 2024, and down 274.99% YoY from $34.97 in Q2 2024.
Novartis Ag (NVS) Times Interest Earned (2009 - 2025) Analysis & Trends
Novartis Ag (NVS) has 15 years of Times Interest Earned data on file, last reported at -$61.19 in Q2 2025.
- Quarterly Times Interest Earned fell 274.99% year-over-year to -$61.19 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$51.52 (up 99.07% YoY) and the FY2025 annual result came in at $15.42, up 6.68% from the prior year.
- Times Interest Earned rose to -$61.19 in Q2 2025 per NVS's latest filing, from -$107.06 in the prior quarter.
- The five-year high for Times Interest Earned was $4827.1 in Q4 2022, with the low at -$169157.8 in Q1 2022.
- Average Times Interest Earned over 5 years is -$13898.5, with a median of -$43.09 recorded in 2023.
- The widest YoY moves for Times Interest Earned: up 121071.03% in 2022, down 4680705.32% in 2022.
- Novartis Ag's Times Interest Earned stood at -$3.99 in 2021, then jumped by 121071.03% to $4827.1 in 2022, then slumped by 100.52% to -$25.0 in 2023, then sank by 328.25% to -$107.06 in 2024, then surged by 42.85% to -$61.19 in 2025.
- Business Quant data shows NVS's Times Interest Earned at -$61.19 in Q2 2025, -$107.06 in Q4 2024, and -$16.32 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 23.39 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -10.80 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -61.19 |
| Dec 31, 2024 | -107.06 |
| Jun 30, 2024 | -16.32 |
| Dec 31, 2023 | -25.00 |
| Jun 30, 2023 | -13.00 |
| Mar 31, 2023 | -25,003.81 |
| Dec 31, 2022 | -92.19 |
| Sep 30, 2022 | -3.27 |
| Jun 30, 2022 | -76.30 |
| Mar 31, 2022 | -3.76 |
| Dec 31, 2021 | -3.99 |
| Sep 30, 2021 | -3.59 |
| Jun 30, 2021 | -77.28 |
| Mar 31, 2021 | -69,310.48 |
| Dec 31, 2020 | -89.56 |
| Sep 30, 2020 | -3.45 |
| Jun 30, 2020 | -10.69 |
| Mar 31, 2020 | 0.19 |
| Jun 30, 2019 | -12.99 |
| Mar 31, 2019 | -1.21 |